What Pharma Needs Next is a podcast for commercial and medical leaders. You’ll hear from life sciences experts on the trends re-shaping biopharma, how technology and data are accelerating their vital work, and ways to improve customer-centricity in the face of HCP and KOL access challenges.
Stefan Schmidt joins Florian Schnappauf to discuss how AI is helping commercial teams prioritize customer interactions. Discover how Bayer is connecting software and a unified data structure to move from a system of record to a system of insights.
Kieron Scrutton joins Florian Schnappauf to discuss architecting an AI-ready enterprise to achieve commercial efficiency at scale. Discover why prioritizing speed and a zero-disruption allowed GSK to move quickly to a next-generation platform and how to identify high-value business processes for AI investment.
In the latest episode, Veeva’s Christoph Bug sits down with Pascal Vande Gucht, UCB and Georgios Tramountanis, Takeda to explore how integrating medical commercial efforts can significantly enhance the HCP experience and drive better patient outcomes.
The latest episode of What Pharma Needs Next with Erica Taylor and Oz Demir from Genentech reveals valuable insights into spearheading marketing transformation, including how to think about behavioral change and success factors as you get started.
In this episode, Pharmaphorum’s Nicole Raleigh interviews Chris Moore, president of Veeva Europe, about some of the trends shaping commercial life sciences. As excitement around AI fluctuates between high potential and hype, Chris outlines potential use cases for life sciences and explains why caution remains necessary. He also discusses how commercial and medical leaders, who understand their customers’ needs, are overcoming field access challenges to accelerate treatment pathways.
Florian Schnappauf speaks to Andy Eeckhout of ADVANZ PHARMA ensuring launch success. Preparing for a launch is a high-stakes gamble for all biopharma companies, particularly those focused on rare diseases. Andy explains how ADVANZ uses data to prepare for a launch, scale across multiple markets, and help MSLs get up-to-speed quickly for an in-depth scientific discussion with experts.
Despite major advances in recent years, it is still too difficult for biopharma field teams to bring together all relevant information to serve HCPs. Florian Schnappauf and Rakesh Vashishta discuss whether the industry asks too much of its field teams, how we can avoid drowning in data, and the changing role of reps to orchestrators of the customer experience.
In this episode, Christoph Bug, VP Global Medical at Veeva, discusses the evolving role of medical affairs with industry experts. They explore how medical teams adapt to the growing demand for scientific exchange and how medical affairs can become a more strategic, data-driven decision-making organization.
Get in touch with Florian Schnappauf or Christoph Bug if you would like to contribute to the podcast or share your feedback.
Discover how Veeva Commercial solutions enhance team collaboration and deliver seamless customer experiences with our connected suite of software, data, and services.
Subscribe to What Pharma Needs Next, a Veeva podcast, to get new episodes as soon as they are released.
